1 of 1
Story summary
- A study presented at the Society for Maternal-Fetal Medicine found that daily aspirin at the first prenatal visit reduced severe preeclampsia by 29% among 18,500 patients at Parkland Hospital.
- A Swedish study of 61,840 deliveries found no significant reduction in preterm preeclampsia with Fetal Medicine Foundation method, with a tendency toward increased term preeclampsia.
- Researchers call for further studies to evaluate aspirin’s efficacy in high-risk populations and tailor prenatal care.
